Skip to content
Nonprofiteer
← MUSCULOSKELETAL TRANSPLANT FOUNDATION INC

Form 990 for tax year 2024

Filed by MUSCULOSKELETAL TRANSPLANT FOUNDATION INC.

Totals

Total revenue
$509,478,090
Total expenses
$491,143,940
Contributions and grants received
$1,005,875
Grants paid
$1,270,444
Program service revenue
$495,952,313
Investment income
$3,871,279
Other revenue
$8,648,623
Total assets, end of year
$323,446,458
Total liabilities, end of year
$197,128,155
Net assets or fund balances, end of year
$126,318,303
Program services expenses (Part IX)
$446,727,711
Management and general expenses
$44,416,229
Fundraising expenses
$0
Program service expenses (Part III)
$446,727,711

Program services were 91.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $1,005,875

  • 2a · Program service revenue: DISTRIBUTION RIGHTS

    total $480,459,139 · related or exempt $480,459,139

  • 2b · Program service revenue: DONOR SCREENING

    total $8,743,075 · related or exempt $8,743,075

  • 2c · Program service revenue: DISTRIB. RIGHTS PAYMEN

    total $6,750,099 · related or exempt $6,750,099

  • 3 · Investment income

    total $2,610,489 · excluded $2,610,489

  • 7a · Gross sales of assets other than inventory

    securities $1,324,941

  • 7b · Less cost or other basis and sales expenses

    securities $0 · other assets $64,151

  • 7c · Gain or loss

    securities $1,324,941 · other assets -$64,151

  • 7d · Net gain or loss

    total $1,260,790 · excluded $1,260,790

  • 10a · Gross sales of inventory

    $3,280,057

  • 10b · Cost of goods sold

    $2,381,412

  • 10c · Net income from sales of inventory

    total $898,645 · unrelated business $898,645

  • 11a · Other revenue: DISTRIB. PARTNER REVEN

    total $4,594,544 · excluded $4,594,544

  • 11b · Other revenue: FREIGHT & DELIVERY REV

    total $1,504,765 · excluded $1,504,765

  • 11c · Other revenue: PARTNER REVENUE

    total $1,068,903 · excluded $1,068,903

  • 11d · All other revenue

    total $581,766 · excluded $581,766

  • 11e · Other revenue, total

    $7,749,978

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $1,257,244 · program services $1,257,244

  • 2 · Grants to domestic individuals

    total $13,200 · program services $13,200

  • 5 · Compensation of officers, directors and key employees

    total $5,255,094 · program services $4,397,269 · management and general $857,825

  • 7 · Other salaries and wages

    total $114,085,142 · program services $95,462,240 · management and general $18,622,902

  • 8 · Pension plan contributions

    total $5,388,727 · program services $4,509,088 · management and general $879,639

  • 9 · Other employee benefits

    total $20,741,086 · program services $17,355,377 · management and general $3,385,709

  • 10 · Payroll taxes

    total $7,885,869 · program services $6,598,605 · management and general $1,287,264

  • 11b · Fees: legal

    total $1,197,691 · program services $1,109,964 · management and general $87,727

  • 11c · Fees: accounting

    total $328,603 · management and general $328,603

  • 11g · Fees: other

    total $4,620,724 · program services $2,635,664 · management and general $1,985,060

  • 12 · Advertising and promotion

    total $3,020,806 · program services $2,922,945 · management and general $97,861

  • 13 · Office expenses

    total $1,508,176 · program services $93,135 · management and general $1,415,041

  • 14 · Information technology

    total $1,321,905 · program services $291,053 · management and general $1,030,852

  • 15 · Royalties

    total $4,234,540 · program services $4,234,540

  • 16 · Occupancy

    total $11,445,913 · program services $11,445,913

  • 17 · Travel

    total $3,615,002 · program services $3,391,811 · management and general $223,191

  • 19 · Conferences, conventions and meetings

    total $4,125,761 · program services $3,566,816 · management and general $558,945

  • 20 · Interest

    total $1,681,188 · program services $1,681,188

  • 22 · Depreciation, depletion and amortization

    total $4,697,463 · program services $3,092,326 · management and general $1,605,137

  • 23 · Insurance

    total $1,432,258 · program services $1,388,398 · management and general $43,860

  • 24a · Other expenses: STORAGE & DISTRIBUTION

    total $150,842,229 · program services $150,808,543 · management and general $33,686 · fundraising $0

  • 24b · Other expenses: PROCESSING COSTS

    total $108,202,847 · program services $108,202,847 · management and general $0 · fundraising $0

  • 24c · Other expenses: RECOVERY EXPENSES

    total $14,471,067 · program services $14,422,879 · management and general $48,188 · fundraising $0

  • 24d · Other expenses: RESEARCH & DEVELOPMENT

    total $4,844,247 · program services $4,844,247 · management and general $0 · fundraising $0

  • 24e · All other expenses

    total $14,927,158 · program services $3,002,419 · management and general $11,924,739

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $0 · end of year $0

  • 2 · Savings and temporary cash investments

    beginning of year $67,145,530 · end of year $65,856,996

  • 4 · Accounts receivable

    beginning of year $66,588,579 · end of year $60,587,502

  • 8 · Inventories for sale or use

    beginning of year $101,069,887 · end of year $109,900,311

  • 9 · Prepaid expenses and deferred charges

    beginning of year $2,511,719 · end of year $3,012,922

  • 10a · Land, buildings and equipment: cost or other basis

    $137,033,353

  • 10b · Land, buildings and equipment: accumulated depreciation

    $101,863,948

  • 10c · Land, buildings and equipment, net

    beginning of year $35,764,285 · end of year $35,169,405

  • 14 · Intangible assets

    beginning of year $4,060,000 · end of year $4,389,864

  • 15 · Other assets

    beginning of year $46,066,971 · end of year $44,529,458

  • 17 · Accounts payable and accrued expenses

    beginning of year $65,882,508 · end of year $55,011,660

  • 18 · Grants payable

    beginning of year $2,828,492 · end of year $3,216,826

  • 19 · Deferred revenue

    beginning of year $85,898,673 · end of year $79,148,574

  • 23 · Secured mortgages and notes payable

    beginning of year $14,347,641 · end of year $17,880,061

  • 25 · Other liabilities

    beginning of year $44,035,486 · end of year $41,871,034

  • 27 · Net assets without donor restrictions

    beginning of year $110,214,171 · end of year $126,318,303

Mission and programs · 2024

Mission

SEE SCHEDULE O

Activities or mission (Part I)

WE PROVIDE INNOVATIVE HUMAN BIOLOGIC SOLUTIONS THAT MAXIMIZE THE GIFT OF DONATION.

  • MTF IS A GLOBAL NONPROFIT ORGANIZATION FOCUSED ON SAVING AND HEALING LIVES, EXPANDING INNOVATION POTENTIAL, HONORING DONATED GIFTS AND SERVING PATIENTS. MTF CONTINUES TO PROVIDE RESEARCH TISSUE AND GRANT FUNDING FOR RESEARCH AND DEVELOPMENT PERFORMED BY ACADEMIC CENTERS AND PIONEERING ENTERPRISES.IN 2024 MTF CONTINUED TO PURSUE ITS MISSION, AND MADE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS THROUGH BOTH INTERNAL AND EXTERNAL DISTRIBUTION RELATIONSHIPS. MTF ORTHOPEDICS FOSTERED NEW PARTNERSHIPS AND EXPANDED (SEE SCHEDULE O)ITS REACH BY LAUNCHING MULTIPLE NEW TISSUE FORMS IN 2024. THESE INNOVATIONS POSITIONED THE FOUNDATION AND OUR PARTNERS TO HELP MORE PATIENTS, WHILE FURTHER MAXIMIZING THE GIFT OF DONATION. MTF ALSO IMPLEMENTED PROCESS EFFICIENCIES THAT WILL CONTINUE TO UTILIZE THE GIFT OF DONATION AND ALLOWS OUR SURGEON COLLABORATORS TO ELEVATE THEIR CONTINUUM OF CARE. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, MTF CONTINUED TO INNOVATE IN PLASTIC SURGERY, WHILE PROVIDING SURGEON EDUCATION AND TRAINING. CONTINUED FOCUS WAS PLACED ON PROCESSING EFFICIENCIES AND DONOR RECOVERY METHODS TO MAXIMIZE THE GIFT OF DONATION WITH THE HELP OF ORGAN PROCUREMENT ORGANIZATIONS. MTF CONTINUED TO BOLSTER ITS INTER-INDUSTRY PARTNERSHIPS,INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE DIVISION CONTINUED GROWING THROUGHOUT 2024, EXPANDING ITS PRESENCE IN THE WOUND HEALING SPACE.MTF GENERATED MORE CLINICAL EFFICACY DATA, AS WELL AS HEALTH CARE ECONOMIC DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY AND VALUE OF ITS TISSUE FORMS.DURING 2024, MTF MAINTAINED ITS COMMITMENT TO ADVANCING KEY PROGRAMS, WITH SIGNIFICANT INVESTMENTS IN THE FOLLOWING AREAS:TISSUE RECOVERY AND PROCESSING: $203,669,233TISSUE DISTRIBUTION: $228,708,012RESEARCH AND DEVELOPMENT: $15,307,466THESE EFFORTS REFLECT MTF'S ONGOING DEDICATION TO SUPPORTING TISSUE DONATION, ENSURING EFFICIENT DISTRIBUTION, AND DRIVING INNOVATION THROUGH RESEARCH.OUR GOAL IS SIMPLE-DO WHAT'S RIGHT FOR PATIENTS, SURGEONS, TISSUE DONORS, AND THEIR FAMILIES THROUGH OUR GUIDING PRINCIPLES:1) WE TRANSFORM BY PROVIDING SAFE, HIGH-QUALITY GRAFTS FROM DONATED HUMAN TISSUES THAT ARE USED IN A GROWING ARRAY OF CLINICAL FIELDS.2) WE COLLABORATE BY FORGING RELATIONSHIPS WITH EXPERTS IN TISSUE AND ORGAN RECOVERY, AS WELL AS LEADING PHYSICIANS AND SCIENTISTS, TO ACCELERATE INNOVATION AND ENSURE THE BEST POSSIBLE EXPERIENCES AND OUTCOMES FOR PATIENTS.3) WE INNOVATE BY ADVANCING THE SCIENCE OF TRANSPLANTATION BY SUPPORTING RESEARCH WITHIN OUR OWN ORGANIZATION AND AMONG CLINICIANS AND RESEARCHERS WORLDWIDE.4) WE GIVE BACK BY REINVESTING IN RESEARCH TO POSITIVELY AFFECT LIVES ACROSS THE GLOBE. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 170,000 DONORS. IN 2024, MTF RECOVERED TISSUE FROM OVER 5,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 7,500 DONORS FOR USE IN GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 800 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 800 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED OVER 550,000 UNITS OF ALLOGRAFT TISSUE DURING 2024.MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE.FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ DONORS-FAMILIES. STORIESABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ RECIPIENTS

    Expenses $446,727,711 · Grants $1,270,444 · Revenue $495,952,313

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • William W Tomford MD

    DIRECTOR

    Total calculated
    $75,000
    From this org
    $75,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    4

  • Donald Hackbarth MD

    CHAIRMAN OF THE BOARD

    Total calculated
    $35,000
    From this org
    $35,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • David Kulber MD

    DIRECTOR

    Total calculated
    $31,054
    From this org
    $31,054
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Joseph D Zuckerman MD

    DIRECTOR

    Total calculated
    $30,000
    From this org
    $30,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Joseph A Buckwalter MD

    DIRECTOR

    Total calculated
    $27,500
    From this org
    $27,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Sharon Gabrielson

    VICE CHAIR

    Total calculated
    $25,000
    From this org
    $25,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Jan Finn RN Msn

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Allan Gross MD

    NON-VOTING DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Gerald Finerman MD

    NON-VOTING DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • David R McAllister MD

    DIRECTOR

    Total calculated
    $27,800
    From this org
    $27,800
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Jeffrey P Orlowski

    DIRECTOR

    Total calculated
    $23,500
    From this org
    $23,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Mia Talmor

    DIRECTOR

    Total calculated
    $12,000
    From this org
    $12,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Joseph A Yaccarino

    PRESIDENT / CEO

    Total calculated
    $958,758
    From this org
    $901,884
    From related orgs
    $0
    Other
    $56,874
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $740,000
    Bonus
    $138,480
    Other
    $23,404
    Deferred
    $20,700
    Nontaxable benefits
    $36,174
    Filer's total
    $958,758

  • Michael J Kawas

    EXECUTIVE VP/ CFO

    Total calculated
    $697,388
    From this org
    $661,023
    From related orgs
    $0
    Other
    $36,365
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $571,170
    Bonus
    $82,030
    Other
    $7,823
    Deferred
    $20,700
    Nontaxable benefits
    $15,665
    Filer's total
    $697,388

  • Marc Long

    EXECUTIVE VP, R & D

    Total calculated
    $557,606
    From this org
    $494,523
    From related orgs
    $0
    Other
    $63,083
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $422,263
    Bonus
    $72,260
    Other
    $0
    Deferred
    $20,645
    Nontaxable benefits
    $42,438
    Filer's total
    $557,606

  • Jennifer Birmingham

    GENERAL COUNSEL

    Total calculated
    $533,939
    From this org
    $477,283
    From related orgs
    $0
    Other
    $56,656
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $412,553
    Bonus
    $64,730
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $35,956
    Filer's total
    $533,939

  • George Herrera

    EXECUTIVE VP, DONOR SERVICES

    Total calculated
    $531,476
    From this org
    $456,333
    From related orgs
    $0
    Other
    $75,143
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $394,763
    Bonus
    $61,570
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $54,443
    Filer's total
    $531,476

  • Michael Oleck

    EXECUTIVE VP, PROCESSING

    Total calculated
    $484,024
    From this org
    $429,512
    From related orgs
    $0
    Other
    $54,512
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $387,082
    Bonus
    $42,430
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $33,812
    Filer's total
    $484,024

  • Brian Leuthner

    VP AND GM PRS FRANCHISE

    Total calculated
    $483,677
    From this org
    $427,269
    From related orgs
    $0
    Other
    $56,408
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $355,439
    Bonus
    $71,830
    Other
    $0
    Deferred
    $20,302
    Nontaxable benefits
    $36,106
    Filer's total
    $483,677

  • Bradley Bailey

    VP AND GM ORTHO FRANCHISE

    Total calculated
    $431,163
    From this org
    $379,683
    From related orgs
    $0
    Other
    $51,480
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $328,783
    Bonus
    $50,900
    Other
    $0
    Deferred
    $19,200
    Nontaxable benefits
    $32,280
    Filer's total
    $431,163

  • Kimberly A Rounds

    VP WOUND CAR

    Total calculated
    $290,209
    From this org
    $290,209
    From related orgs
    $0
    Other
    $0
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $290,209
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $290,209

  • Sarah Brusch

    EXECUTIVE SPECIALIST - STAR

    Total calculated
    $547,863
    From this org
    $476,836
    From related orgs
    $0
    Other
    $71,027
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $100,000
    Bonus
    $5,000
    Other
    $371,836
    Deferred
    $13,322
    Nontaxable benefits
    $57,705
    Filer's total
    $547,863

  • Floyd Vaughan

    EXECUTIVE SPECIALIST - STAR

    Total calculated
    $538,385
    From this org
    $458,047
    From related orgs
    $0
    Other
    $80,338
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $100,000
    Bonus
    $0
    Other
    $358,047
    Deferred
    $18,033
    Nontaxable benefits
    $62,305
    Filer's total
    $538,385

  • Nathan Rice

    SR. PORTFOLIO MANAGER

    Total calculated
    $528,802
    From this org
    $456,446
    From related orgs
    $0
    Other
    $72,356
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $176,304
    Bonus
    $3,553
    Other
    $276,589
    Deferred
    $20,700
    Nontaxable benefits
    $51,656
    Filer's total
    $528,802

  • Keith Morocko

    VP, CONTRACT ADMIN

    Total calculated
    $482,540
    From this org
    $406,599
    From related orgs
    $0
    Other
    $75,941
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $342,636
    Bonus
    $0
    Other
    $63,963
    Deferred
    $17,361
    Nontaxable benefits
    $58,580
    Filer's total
    $482,540

  • Gregory Adams

    NATIONAL SALES DIRECTOR, STAR

    Total calculated
    $471,676
    From this org
    $407,106
    From related orgs
    $0
    Other
    $64,570
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $213,357
    Bonus
    $7,500
    Other
    $186,249
    Deferred
    $20,700
    Nontaxable benefits
    $43,870
    Filer's total
    $471,676

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 7
NON-FIXED PAYMENTS PROVIDED CERTAIN COMPONENTS OF EXECUTIVE COMPENSATION ARE NON-FIXED AND MAY VARY FROM YEAR TO YEAR BASED ON DISCRETIONARY FACTORS. THESE AMOUNTS ARE DESIGNED TO RECOGNIZE INDIVIDUAL AND ORGANIZATIONAL PERFORMANCE AND ARE DETERMINED AFTER CONSIDERATION OF THE FOUNDATION'S PROGRAMMATIC ACCOMPLISHMENTS, STRATEGIC PRIORITIES, AND OVERALL FINANCIAL AND MARKET CONDITIONS. THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS IS RESPONSIBLE FOR REVIEWING, EVALUATING, AND APPROVING ALL NON-FIXED ELEMENTS OF COMPENSATION FOR THE FOUNDATION'S CHIEF EXECUTIVE OFFICER AND OTHER SENIOR EXECUTIVE OFFICERS. THE COMMITTEE'S DETERMINATIONS ARE GUIDED BY COMPARATIVE COMPENSATION DATA, PERFORMANCE EVALUATIONS, AND THE FOUNDATION'S COMPENSATION PHILOSOPHY TO ENSURE THAT ALL PAYMENTS ARE REASONABLE AND CONSISTENT WITH THE ORGANIZATION'S EXEMPT PURPOSES.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • DEUTCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH (DIZG GMBH)

    C · TISSUE DISTRIBUTION · GM

    Directly controlled by BIOCON

Provenance

Return type
form_990
Tax year
2024
Filed
13 November 2025
IRS schema version
2024v5.2
Source object
202533189349303063

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.